Market Context — Why This Technology, Why Now

The global shift towards personalized medicine and advanced biomanufacturing is creating immense pressure for more precise, scalable, and affordable genetic tools. Regulatory bodies are also pushing for higher quality and reproducibility in biological products. This technology directly supports these trends by enabling superior control in DNA synthesis and modification, crucial for developing next-generation therapeutics, diagnostics, and sustainable bio-based products, thereby driving competitive advantage in a rapidly evolving market.

Key Competitive Advantages
01

Achieves precise single-strand DNA cleavage at specific sites, enhancing genetic editing and diagnostic applications.

02

Reduces overall DNA manufacturing costs by enabling inexpensive production of novel primer structures.

03

Enables simple and highly efficient production of double-stranded DNA with sticky ends, accelerating downstream genetic manipulation.

Market Opportunity
Gene Therapy and Editing
$650M–$2B globally (AI est.)
Precise DNA cleavage at specific sites could improve the efficiency and safety of gene-editing technologies like CRISPR-Cas9, accelerating therapeutic drug development.
Biopharmaceutical companies Gene therapy developers Academic research institutions
Diagnostic Reagents and Testing
$550M–$2B globally (AI est.)
A stable supply of high-quality double-stranded DNA could contribute to improved performance and cost reduction for pathogen detection and genetic disease diagnostic kits.
Clinical diagnostics manufacturers Medical device companies Biotechnology research suppliers
Synthetic Biology and Bioproduction
$350M–$2B globally (AI est.)
In the production of chemicals and pharmaceuticals using microorganisms, optimizing gene manipulation efficiency and reducing costs could directly lead to increased productivity.
Industrial biotechnology firms Specialty chemical manufacturers Contract research organizations (CROs)
IP Defensibility — Why Competitors Can't Replicate This
What This Patent Covers

This patent protects a novel primer structure and its use in apparatuses and methods for manufacturing double-stranded DNA, specifically enabling precise single-strand cleavage. The claims are robust, having withstood rigorous examination, and establish a broad scope of protection for the core technology.

Competitive White Space

This patent primarily covers the primer's chemical structure and its direct application in DNA synthesis. Licensees could develop additional IP around automated high-throughput screening systems utilizing this primer or novel delivery methods for the resulting double-stranded DNA in vivo applications.

Economic Impact
~$0.2M/year estimated DNA manufacturing cost reduction per facility (est.)
estimated ROI · USD · AI analysis
ROI Calculation Logic

For companies spending ~$0.65M annually on DNA material costs, this technology's inexpensive primer manufacturing and process efficiency could yield approximately 30% cost reduction. This translates to a direct annual saving of ~$0.2M (AI est.) in material and manufacturing expenses. Furthermore, reduced failure rates from precise cleavage could lower re-experimentation costs and shorten research timelines, leading to significant indirect economic benefits.

Speed to Market
4× faster than in-house development
Adopting this technology could significantly reduce the foundational research period for complex primer design and synthesis. The primer structure and manufacturing method described in the patent are already established, eliminating the need for licensees to conduct R&D from scratch. This could shorten a typical 4-year in-house development cycle to approximately 1 year. Primer chemical synthesis is compatible with existing equipment, minimizing additional capital investment.
Competitive Positioning

X: DNA Processing Precision
Y: Manufacturing Cost Efficiency

Business Models & Applications
🧪 DNA Synthesis Contract Services
Leverage this technology to offer contract synthesis services for double-stranded DNA with specific sticky ends or DNA requiring precise single-strand cleavage, targeting research institutions and pharmaceutical companies. Combines high quality with cost competitiveness.
🧬 Gene Editing Toolkit Provision
Commercialize this technology's primers as a gene editing toolkit. This could help researchers perform genetic manipulations more simply and precisely, contributing to increased R&D efficiency.
🔬 Diagnostic Reagent & Research Assay Development
Utilize sticky-end DNA produced by this technology as a foundational material for highly sensitive pathogen detection probes or genetic disease diagnostic reagents. This could accelerate the development and market launch of new diagnostic technologies.
Adjacent Application Opportunities
🔬 Clinical Diagnostics & Medicine
Next-Generation PCR Diagnostic Kits
This technology's primers could enable the development of PCR diagnostic kits for more sensitive and specific amplification and detection of viral or bacterial genetic regions. Precise cleavage control via the degradable protecting group could reduce false positive/negative risks, improving diagnostic accuracy by an estimated 15-20%.
🌾 Agricultural & Food Biotechnology
Enhanced Crop Genome Editing
This technology could significantly improve genome editing efficiency in crop breeding. By precisely cleaving and ligating specific DNA sites, it could enable faster and more cost-effective introduction or modification of target genes, potentially boosting crop yield by 10-20% or enhancing disease resistance.
🏭 Materials Science & Nanotechnology
Advanced DNA Nanostructure Assembly
Double-stranded DNA with sticky ends, produced using this technology, could enable the construction of more complex and stable self-assembling DNA nanostructures. This opens avenues for next-generation biosensors and drug delivery systems, potentially increasing structural complexity by 2x-3x.
Integration Roadmap — Estimated 24-Month Deployment
Technology Evaluation & Prototype Construction
Duration: 6 months
Evaluate the reproducibility of the primer synthesis and double-stranded DNA manufacturing processes. Verify compatibility with existing DNA synthesis and amplification equipment, and potentially construct a small-scale prototype.
Application Development & Validation
Duration: 9 months
Advance product development tailored for specific target markets, such as gene editing tools. Detailed validation of the manufactured DNA's functionality, stability, and specificity is expected, aiming for performance optimization.
Scale-Up & Market Launch Preparation
Duration: 9 months
Implement manufacturing process scale-up and cost-efficiency optimization. Establish quality control systems, address regulatory requirements, and prepare for market introduction.
Technical Feasibility
The core primer of this technology can be manufactured using existing chemical synthesis techniques, minimizing the need for special new capital investment. The patent claims clearly define the primer's structural formula and detail its manufacturing method, allowing licensees to quickly establish synthesis processes. Furthermore, the double-stranded DNA manufacturing apparatus can utilize general-purpose DNA amplification equipment, indicating high compatibility with existing bio-research and production lines.
Success Scenario
Upon adopting this technology, a licensee's R&D department could reduce DNA processing failure rates in gene editing experiments by 20%. This could decrease experimental repetitions and shorten development timelines by an average of 3 months. Additionally, the manufacturing division could reduce annual DNA material costs by up to 30% due to the inexpensive primers, significantly enhancing product cost competitiveness.
Patent Record
APPLICATION NO.
特願2021-535462
REGISTRATION NO.
7521816
FILING DATE
2020/07/31
GRANT DATE
2024/07/16
EXPIRATION DATE
2040/07/31
PATENT HOLDER
国立研究開発法人科学技術振興機構
Examination History
2023年03月15日
出願審査請求書
2024年02月06日
拒絶理由通知書
2024年03月15日
手続補正書（自発・内容）
2024年03月15日
意見書
2024年07月02日
特許査定